E-cigarettes 'help thousands successfully quit smoking'

Conclusion Stopping smoking remains the best thing you can possibly do for your health. Anything that can help reduce the number of people who smoke is likely to have a good impact on health. But although this study found e-cigarette use was linked to an increase in successful quit attempts, there are a number of things to be aware of: Attempting to quit with e-cigarettes alone may not be as helpful as attempting to quit using an NHS stop smoking service. Getting support and help for a quit attempt is thought to increase your chances of success fourfold. You can use NHS services and e-cigarettes together if you wish. The study can't prove using e-cigarettes is the direct reason for the improved rate of quit attempts as other confounding factors may have been involved. Some of the study results were surprising – for example, the researchers calculated that the rise in the legal age for smoking from 16 to 18 was associated with a bigger increase in quitting success rates than you'd expect. This casts some doubt over the results. Questions remain about whether e-cigarettes are really safe. While there's still work to do on this, Public Health England estimates the aids are 95% safer than using tobacco cigarettes. The important thing if you're a smoker is to give yourself the best possible chance of stopping smoking for good.   Links To The Headlines E-cigarettes 'help more smokers quit'. BBC News, September 14 2016 E-cigarette...
Source: NHS News Feed - Category: Consumer Health News Tags: Lifestyle/exercise Medication Heart/lungs Cancer Source Type: news

Related Links:

Advances in antiretroviral therapy (ART) have dramatically increased the life expectancy of people living with HIV (PLWH); however, PLWH still suffer from inflammation-related diseases such as cardiovascular disease, type II diabetes, cancer, and dementia at higher rates and at younger ages than uninfected individuals (Nemeth et al 2015, Valdez et al 2016). Although it has been established that persistent immune activation and inflammation contribute to non-AIDS pathologies in PLWH who are on suppressive antiretroviral therapy (ART) (Hunt 2012), the factors contributing to sustained inflammation in otherwise healthy PLWH h...
Source: Psychoneuroendocrinology - Category: Psychiatry Authors: Source Type: research
This article reviews the effects of DMARDs on the expression and function of P-gp, MRPs, and BCRP and the related molecular mechanism in the treatment of AID. Graphical abstract
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Conclusion:In hemodynamically stable patients with chest pain, sinus tachycardia aids in the identification of patients unlikely to have type I MI, especially in those with HR> 120 bpm.
Source: Dr. Smith's ECG Blog - Category: Cardiology Authors: Source Type: blogs
Abstract Because of the level of attention it received due to its role as the principal HIV coreceptor, CCR5 has been described as a 'celebrity' chemokine receptor. Here we describe the development of CCR5 inhibitory strategies that have been developed for HIV therapy and which are now additionally being considered for use in HIV prevention and cure. The wealth of CCR5-related tools that have been developed during the intensive investigation of CCR5 as an HIV drug target can now be turned towards the study of CCR5 as a model chemokine receptor. We also summarize what is currently known about the cell biology and p...
Source: Cytokine - Category: Molecular Biology Authors: Tags: Cytokine Source Type: research
Previous studies have reported an increased risk for certain types of cancer in the HIV-infected population. The aim of this study was to assess the risk for cancer in people with AIDS (PWA) in comparison with the general population in São Paulo (Brazil), between 1997 and 2012. A population-based registry linkage study was carried out to assess the risk for cancer, using a standardized incidence ratio (SIR) approach. A total of 480 102 person-years, of which 337 941 (70.4%) person-years were men, were included in the analysis. Around 2074 cancer cases were diagnosed among PWA, of which 51.0% were non-A...
Source: European Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Research Paper: Life Style Source Type: research
(MedPage Today) -- Greatest risk reduction among AIDS-defining cancers
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
Abstract Background: Viral suppression is a primary marker of HIV treatment success. Persons with HIV are at increased risk for AIDS-defining cancer (ADC) and several types of non-AIDS-defining cancer (NADC), some of which are caused by oncogenic viruses. Objective: To determine whether viral suppression is associated with decreased cancer risk. Design: Prospective cohort. Setting: Department of Veterans Affairs. Participants: HIV-positive veterans (n = 42 441) and demographically matched uninfected veterans (n = 104 712) from 1999 to 2015. Measurements: Standardized ca...
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Tags: Ann Intern Med Source Type: research
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, AIDS, News, Source Type: news
(American College of Physicians) Early, sustained antiretroviral therapy (ART), which results in long-term viral suppression, helps to prevent AIDS-defining cancers and also non-AIDS-defining cancers, to a lesser degree. However, patients with long-term viral suppression still had excess cancer risk compared to uninfected patients. The study, published in Annals of Internal Medicine, is the first to examine the effects of prolonged periods of viral suppression and potential cancer prevention benefits for the aging population of persons living with HIV.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Chantix | Health | Heart | HIV AIDS | International Medicine & Public Health | Legislation | Nicotine | Nicotine Replacement Therapy | Science | Smokers | Sports Medicine | Study